Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan for Arthrofibrosis Following Total Knee Arthroplasty
NCT05157464Phase 4Withdrawn
- Sponsor
- NYU Langone Health
- Start
- Sep 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of losartan in Arthrofibrosis, sponsored by NYU Langone Health. Planned start Sep 2023; status: withdrawn.
02
Drugs
losartan
03
Conditions
Arthrofibrosis
Beyond the preview
Go deeper on NCT05157464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05157464.